Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Adamis Pharmaceuticals Corporation stock | $0.87

Own Adamis Pharmaceuticals Corporation stock in just a few minutes.

Fact checked

Adamis Pharmaceuticals Corporation is a drug manufacturers-specialty & generic business based in the US. Adamis Pharmaceuticals Corporation shares (ADMP) are listed on the NASDAQ and all prices are listed in US Dollars. Adamis Pharmaceuticals Corporation employs 131 staff and has a trailing 12-month revenue of around USD$18.4 million.

How to buy shares in Adamis Pharmaceuticals Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Adamis Pharmaceuticals Corporation. Find the stock by name or ticker symbol: ADMP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Adamis Pharmaceuticals Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$0.87, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Adamis Pharmaceuticals Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Adamis Pharmaceuticals Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Adamis Pharmaceuticals Corporation share price

Use our graph to track the performance of ADMP stocks over time.

Adamis Pharmaceuticals Corporation shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$0.87
52-week rangeUSD$0.27 - USD$1.51
50-day moving average USD$0.5141
200-day moving average USD$0.7314
Wall St. target priceUSD$1
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.831

Buy Adamis Pharmaceuticals Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Adamis Pharmaceuticals Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adamis Pharmaceuticals Corporation price performance over time

Historical closes compared with the close of $0.87 from 2020-10-19

1 week (2021-01-07) 24.29%
1 month (2020-12-17) 67.31%
3 months (2020-10-16) -5.43%
6 months (2020-07-17) 12.99%
1 year (2020-01-17) 11.15%
2 years (2019-01-17) -69.79%
3 years (2018-01-17) 4.1
5 years (2016-01-15) 4.43

Adamis Pharmaceuticals Corporation financials

Revenue TTM USD$18.4 million
Gross profit TTM USD$6.3 million
Return on assets TTM -37.61%
Return on equity TTM -102.54%
Profit margin -188.31%
Book value $0.293
Market capitalisation USD$48.5 million

TTM: trailing 12 months

Shorting Adamis Pharmaceuticals Corporation shares

There are currently 2.4 million Adamis Pharmaceuticals Corporation shares held short by investors – that's known as Adamis Pharmaceuticals Corporation's "short interest". This figure is 9.1% down from 2.7 million last month.

There are a few different ways that this level of interest in shorting Adamis Pharmaceuticals Corporation shares can be evaluated.

Adamis Pharmaceuticals Corporation's "short interest ratio" (SIR)

Adamis Pharmaceuticals Corporation's "short interest ratio" (SIR) is the quantity of Adamis Pharmaceuticals Corporation shares currently shorted divided by the average quantity of Adamis Pharmaceuticals Corporation shares traded daily (recently around 6.1 million). Adamis Pharmaceuticals Corporation's SIR currently stands at 0.4. In other words for every 100,000 Adamis Pharmaceuticals Corporation shares traded daily on the market, roughly 400 shares are currently held short.

However Adamis Pharmaceuticals Corporation's short interest can also be evaluated against the total number of Adamis Pharmaceuticals Corporation shares, or, against the total number of tradable Adamis Pharmaceuticals Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adamis Pharmaceuticals Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Adamis Pharmaceuticals Corporation shares in existence, roughly 30 shares are currently held short) or 0.0261% of the tradable shares (for every 100,000 tradable Adamis Pharmaceuticals Corporation shares, roughly 26 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Adamis Pharmaceuticals Corporation.

Find out more about how you can short Adamis Pharmaceuticals Corporation stock.

Adamis Pharmaceuticals Corporation share dividends

We're not expecting Adamis Pharmaceuticals Corporation to pay a dividend over the next 12 months.

Have Adamis Pharmaceuticals Corporation's shares ever split?

Adamis Pharmaceuticals Corporation's shares were split on a 1:17 basis on 13 December 2013. So if you had owned 17 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adamis Pharmaceuticals Corporation shares – just the quantity. However, indirectly, the new 1600% higher share price could have impacted the market appetite for Adamis Pharmaceuticals Corporation shares which in turn could have impacted Adamis Pharmaceuticals Corporation's share price.

Adamis Pharmaceuticals Corporation share price volatility

Over the last 12 months, Adamis Pharmaceuticals Corporation's shares have ranged in value from as little as $0.27 up to $1.51. A popular way to gauge a stock's volatility is its "beta".

ADMP.US volatility(beta: 1.61)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamis Pharmaceuticals Corporation's is 1.6105. This would suggest that Adamis Pharmaceuticals Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Adamis Pharmaceuticals Corporation overview

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site